|
Median
|
2.50%
|
97.50%
|
---|
MDS-UPDRS-II (motor)
|
Intercept
|
13.522
|
0.076
|
25.197
|
Time
|
−0.042
|
−0.095
|
0.011
|
Age at Baseline
|
0.035
|
−0.147
|
0.211
|
Education
|
−0.108
|
−0.604
|
0.419
|
Gender (=Male)
|
0.805
|
−2.381
|
3.904
|
DOI*
|
0.549
|
0.169
|
0.919
|
HAMD*
|
0.283
|
0.087
|
0.492
|
MoCA*
|
−0.320
|
−0.584
|
−0.052
|
LEDD
|
1.066
|
−0.570
|
2.612
|
MDS-UPDRS-I (non-motor)
|
Intercept
|
26.351
|
10.126
|
38.947
|
Time
|
−0.016
|
−0.075
|
0.046
|
Age at Baseline
|
0.075
|
−0.098
|
0.250
|
Education*
|
−0.575
|
−1.075
|
−0.107
|
Gender (=Male)
|
−1.925
|
−5.203
|
1.036
|
DOI
|
0.037
|
−0.306
|
0.397
|
HAMD*
|
0.439
|
0.217
|
0.693
|
MoCA
|
−0.311
|
−0.609
|
0.008
|
LEDD
|
0.360
|
−1.250
|
1.993
|
Imbalance
|
Intercept
|
6.096
|
−6.903
|
23.289
|
Time*
|
−0.109
|
−0.579
|
−0.001
|
Age at Baseline
|
0.181
|
−0.021
|
0.853
|
Education
|
−0.148
|
−1.184
|
0.823
|
Gender (=Male)*
|
−4.657
|
−21.182
|
−0.790
|
DOI
|
0.312
|
−0.027
|
2.233
|
HAMD
|
0.023
|
−0.302
|
0.541
|
MoCA*
|
−0.589
|
−2.336
|
−0.164
|
LEDD*
|
2.827
|
0.675
|
11.893
|
- Abbreviations: MDS-UPDRS the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale, DOI duration of illness, HAMD Hamilton Depression Rating Scale, MoCA the Montreal Cognitive Assessment, LEDD Levodopa equivalent daily dose
- *95% credible interval does not include 0, indicating the signifiance